Business

VOLUNTARY ANNOUNCEMENT - IND FOR SUBCUTANEOUS INFUSION OF BJ007 FOR INJECTION (SC) WAS APPROVED BY U.S. FDA

VOLUNTARY ANNOUNCEMENT - IND FOR SUBCUTANEOUS INFUSION OF BJ007 FOR INJECTION (SC) WAS APPROVED BY U.S. FDA

articleShanghai Bao Pharmaceuticals Co Ltd Class HJune 10, 20263/news/voluntary-announcement-ind-for-subcutaneous-infusion-of-bj007-for-injection-sc-was-approved-by-us-fda
VOLUNTARY ANNOUNCEMENT - IND FOR SUBCUTANEOUS INFUSION OF BJ007 FOR INJECTION (SC) WAS APPROVED BY U.S. FDA

About this update from Shanghai Bao Pharmaceuticals Co Ltd Class H

Shanghai Bao Pharmaceuticals Co Ltd Class H (2659) Press ReleaseView Attachment

View stock analysis, news, and events for Shanghai Bao Pharmaceuticals Co Ltd Class H